Impact of a pharmacist-driven tardive dyskinesia screening service.

The Mental Health Clinician Pub Date : 2021-07-16 eCollection Date: 2021-07-01 DOI:10.9740/mhc.2021.07.248
Niyati Butala, Andrew Williams, Jamie Kneebusch, Melissa Mitchell
{"title":"Impact of a pharmacist-driven tardive dyskinesia screening service.","authors":"Niyati Butala,&nbsp;Andrew Williams,&nbsp;Jamie Kneebusch,&nbsp;Melissa Mitchell","doi":"10.9740/mhc.2021.07.248","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Tardive dyskinesia (TD) is defined as involuntary movements that can develop with prolonged antipsychotic use. Regular monitoring using the Abnormal Involuntary Movement Scale (AIMS) is recommended to be conducted every 3 to 6 months for early recognition, although the AIMS is underused. Several studies have investigated risk factors that may be associated with TD, including age, sex, and long-term antipsychotic use. This study aimed to increase the monitoring and treatment of TD for those assessed to be at higher risk.</p><p><strong>Methods: </strong>This was a prospective quality improvement study on the effectiveness of a psychiatric pharmacist-driven TD screening service (PPDTSS) in an inpatient psychiatric facility. Participants were composed of adult patients admitted between May and November 2018. Patients were screened daily by a clinical pharmacist and, if determined to be high risk based on studied risk factors, prioritized to receive a formal TD screening via the AIMS. The primary objective was to optimize standard of care by increasing the number of AIMS screenings conducted. The secondary objective was to increase the treatment of TD.</p><p><strong>Results: </strong>A total of 402 patients were assessed prior to implementation of the PPDTSS, and 390 patients were screened following implementation. The PPDTSS increased the number of AIMS screenings attempted by 85.1% for high-risk individuals. Of the 75 patients who had an AIMS screening attempted in the postintervention group, 46 (61.3%) had an AIMS screening completed, of which 3 (6.5%) were positive.</p><p><strong>Discussion: </strong>The results of this study demonstrate that psychiatric pharmacists can be used to improve the regular monitoring of patients at high risk for TD.</p>","PeriodicalId":22710,"journal":{"name":"The Mental Health Clinician","volume":"11 4","pages":"248-253"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7e/d8/i2168-9709-11-4-248.PMC8287863.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Mental Health Clinician","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9740/mhc.2021.07.248","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/7/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: Tardive dyskinesia (TD) is defined as involuntary movements that can develop with prolonged antipsychotic use. Regular monitoring using the Abnormal Involuntary Movement Scale (AIMS) is recommended to be conducted every 3 to 6 months for early recognition, although the AIMS is underused. Several studies have investigated risk factors that may be associated with TD, including age, sex, and long-term antipsychotic use. This study aimed to increase the monitoring and treatment of TD for those assessed to be at higher risk.

Methods: This was a prospective quality improvement study on the effectiveness of a psychiatric pharmacist-driven TD screening service (PPDTSS) in an inpatient psychiatric facility. Participants were composed of adult patients admitted between May and November 2018. Patients were screened daily by a clinical pharmacist and, if determined to be high risk based on studied risk factors, prioritized to receive a formal TD screening via the AIMS. The primary objective was to optimize standard of care by increasing the number of AIMS screenings conducted. The secondary objective was to increase the treatment of TD.

Results: A total of 402 patients were assessed prior to implementation of the PPDTSS, and 390 patients were screened following implementation. The PPDTSS increased the number of AIMS screenings attempted by 85.1% for high-risk individuals. Of the 75 patients who had an AIMS screening attempted in the postintervention group, 46 (61.3%) had an AIMS screening completed, of which 3 (6.5%) were positive.

Discussion: The results of this study demonstrate that psychiatric pharmacists can be used to improve the regular monitoring of patients at high risk for TD.

Abstract Image

药剂师驱动的迟发性运动障碍筛查服务的影响。
迟发性运动障碍(TD)被定义为随抗精神病药物长期使用而出现的不自主运动。建议每3至6个月使用异常不自主运动量表(AIMS)进行定期监测,以便及早发现,尽管AIMS尚未得到充分利用。一些研究调查了可能与TD相关的危险因素,包括年龄、性别和长期使用抗精神病药物。本研究旨在加强对那些被评估为高危人群的TD监测和治疗。方法:这是一项关于精神科药剂师驱动的TD筛查服务(PPDTSS)在精神科住院病人中的有效性的前瞻性质量改进研究。参与者由2018年5月至11月入院的成年患者组成。患者每天由临床药剂师进行筛查,如果根据研究的风险因素确定为高风险,则优先通过AIMS接受正式的TD筛查。主要目的是通过增加AIMS筛查的数量来优化护理标准。第二个目标是增加对TD的治疗。结果:实施PPDTSS前共评估了402例患者,实施后筛查了390例患者。PPDTSS使高危人群的AIMS筛查次数增加了85.1%。在干预后组尝试AIMS筛查的75例患者中,46例(61.3%)完成了AIMS筛查,其中3例(6.5%)阳性。讨论:本研究结果表明,精神科药师可用于改善对TD高危患者的定期监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信